$0.940
-0.044 (-4.67%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRDF Prediction & Forecast by Similar Chart Analysis
Alphio's CRDF stock price prediction model matches the current Cardiff Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.93 (-0.81%). The 1-week path is $0.93 (-0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cardiff Oncology Inc Stock?
Cardiff Oncology Inc is currently priced at $0.94, which is significantly lower than its previous highs and the average analyst target of $4. However, the stock has shown a 6.81% increase over the last five days, suggesting some short-term momentum. The RSI is at 44.76, indicating that the stock is neither overbought nor oversold, which may suggest a hold position. The main risk is the ongoing legal dispute regarding the onvansertib license, which could impact future financing and development, as highlighted by multiple analysts downgrading their ratings due to this uncertainty.
CRDF stock price ended at $0.94 on Friday, after losing -4.67%
Cardiff Oncology Inc (CRDF) last closed at $0.94, losing -4.67%. These facts feed the 1-day and 1-week CRDF price prediction above.
Forecast Drivers
Cardiff Oncology Inc (CRDF) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRDF, ranked by similarity.
Seasonality analysis for CRDF
Historically the probability of a positive August return for CRDF is 34.92%. February offers the highest probability of a positive month at 53.45%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRDF
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.11 | $3.20 | $3.60 | +240.32% |
| Sep 2026 | $3.03 | $3.35 | $3.67 | +256.51% |
| Oct 2026 | $3.30 | $3.35 | $3.56 | +256.51% |
| Nov 2026 | $3.32 | $3.35 | $3.53 | +256.51% |
| Dec 2026 | $2.97 | $3.35 | $3.61 | +256.51% |
In 2026, Cardiff Oncology Inc (CRDF) is projected to range from $2.97 to $3.67.
Cardiff Oncology Inc 2026 monthly forecast
In Aug 2026, Cardiff Oncology Inc is projected to average $3.20, with a low of $3.11 and high of $3.60.
In Sep 2026, Cardiff Oncology Inc is projected to average $3.35, with a low of $3.03 and high of $3.67.
In Oct 2026, Cardiff Oncology Inc is projected to average $3.35, with a low of $3.30 and high of $3.56.
In Nov 2026, Cardiff Oncology Inc is projected to average $3.35, with a low of $3.32 and high of $3.53.
In Dec 2026, Cardiff Oncology Inc is projected to average $3.35, with a low of $2.97 and high of $3.61.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.